Deva Holding AS - Asset Resilience Ratio

Latest as of September 2025: 2.10%

Deva Holding AS (DEVA) has an Asset Resilience Ratio of 2.10% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Deva Holding AS total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

TL745.77 Million

≈ $16.70 Million USD Cash + Short-term Investments

Total Assets

TL35.50 Billion

≈ $795.16 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2024)

This chart shows how Deva Holding AS's Asset Resilience Ratio has changed over time. See Deva Holding AS book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Deva Holding AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DEVA stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	TL0.00	0%
Short-term Investments	TL745.77 Million	2.1%
Total Liquid Assets	TL745.77 Million	2.10%

Asset Resilience Insights

Limited Liquidity: Deva Holding AS maintains only 2.10% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Deva Holding AS Industry Peers by Asset Resilience Ratio

Compare Deva Holding AS's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Deva Holding AS (2005–2024)

The table below shows the annual Asset Resilience Ratio data for Deva Holding AS.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.06%	TL1.21 Billion ≈ $27.01 Million	TL29.73 Billion ≈ $665.86 Million	-5.05pp
2023-12-31	9.11%	TL2.95 Billion ≈ $66.10 Million	TL32.40 Billion ≈ $725.77 Million	+0.59pp
2022-12-31	8.52%	TL734.62 Million ≈ $16.45 Million	TL8.62 Billion ≈ $193.16 Million	-4.19pp
2019-12-31	12.70%	TL269.26 Million ≈ $6.03 Million	TL2.12 Billion ≈ $47.47 Million	+12.70pp
2018-12-31	0.01%	TL86.10K ≈ $1.93K	TL1.67 Billion ≈ $37.37 Million	-0.01pp
2008-12-31	0.01%	TL73.00K ≈ $1.64K	TL489.79 Million ≈ $10.97 Million	-0.05pp
2006-12-31	0.06%	TL177.00K ≈ $3.96K	TL290.88 Million ≈ $6.52 Million	+0.05pp
2005-12-31	0.01%	TL30.00K ≈ $671.92	TL273.18 Million ≈ $6.12 Million	--

pp = percentage points

About Deva Holding AS

IS:DEVA Turkey Drug Manufacturers - Specialty & Generic

Market Cap

$295.90 Million

TL13.21 Billion TRY

Market Cap Rank

#15014 Global

#152 in Turkey

Share Price

TL66.05

Change (1 day)

-0.38%

52-Week Range

TL52.35 - TL80.65

All Time High

TL102.39